AOD9604
A modified fragment of human growth hormone studied specifically for fat metabolism without affecting blood sugar or growth.
An experimental peptidomimetic investigated in preclinical models for targeting the blood supply of fat tissue, with research focused on adipose reduction.
In the literature, Adipotide appears most often in work focused on fat loss, weight loss and visceral fat loss. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Adipotide is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A modified fragment of human growth hormone studied specifically for fat metabolism without affecting blood sugar or growth.
An NNMT inhibitor studied for increasing cellular metabolism, reducing fat mass, and preserving muscle during weight loss research.
An amylin analog studied for appetite regulation and weight loss, often researched alongside GLP-1 compounds.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.